Laboratoire d'Oncogénétique, Institut Curie-Hôpital René Huguenin, 35 rue Dailly, 92210 Saint-Cloud, France.
Breast Cancer Res Treat. 2012 Jun;133(3):1179-90. doi: 10.1007/s10549-012-2009-5. Epub 2012 Apr 5.
Hereditary breast cancers account for up to 5-10 % of breast cancers and a majority are related to the BRCA1 and BRCA2 genes. However, many families with breast cancer predisposition do not carry any known mutations for BRCA1 and BRCA2 genes. We explored the incidence of rare large rearrangements in the coding, noncoding and flanking regions of BRCA1/2 and in eight other candidate genes--CHEK2, BARD1, ATM, RAD50, RAD51, BRIP1, RAP80 and PALB2. A dedicated zoom-in CGH-array was applied to screen for rearrangements in 472 unrelated French individuals from breast-ovarian cancer families that were being followed in eight French oncogenetic laboratories. No new rearrangement was found neither in the genomic regions of BRCA1/2 nor in candidate genes, except for the CHEK2 and BARD1 genes. Three heterozygous deletions were detected in the 5' and 3' flanking regions of BRCA1. One large deletion introducing a frameshift was identified in the CHEK2 gene in two families and one heterozygous deletion was detected within an intron of BARD1. The study demonstrates the usefulness of CGH-array in routine genetic analysis and, aside from the CHEK2 rearrangements, indicates there is a very low incidence of large rearrangements in BRCA1/2 and in the other eight candidate genes in families already explored for BRCA1/2 mutations. Finally, next-generation sequencing should bring new information about point mutations in intronic and flanking regions and also medium size rearrangements.
遗传性乳腺癌占乳腺癌的 5-10%,其中大多数与 BRCA1 和 BRCA2 基因有关。然而,许多有乳腺癌易感性的家族并没有携带 BRCA1 和 BRCA2 基因的已知突变。我们探讨了 BRCA1/2 的编码区、非编码区和侧翼区以及其他八个候选基因-CHEK2、BARD1、ATM、RAD50、RAD51、BRIP1、RAP80 和 PALB2 中罕见的大片段重排的发生率。我们应用专用的 CGH 微阵列对 472 名来自乳腺癌-卵巢癌家族的、在 8 个法国肿瘤遗传学实验室接受随访的无关联法国个体进行筛查,以寻找重排。除了 CHEK2 和 BARD1 基因外,在 BRCA1/2 和候选基因的基因组区域中均未发现新的重排。在 BRCA1 的 5'和 3'侧翼区域检测到 3 个杂合性缺失。在两个家族中,在 CHEK2 基因中发现了一个引入移码的大片段缺失,在 BARD1 的内含子中检测到一个杂合性缺失。该研究证明了 CGH 微阵列在常规遗传分析中的有用性,除了 CHEK2 重排外,还表明在已经探索过 BRCA1/2 突变的家族中,BRCA1/2 和其他八个候选基因中大片段重排的发生率非常低。最后,下一代测序应该会提供关于内含子和侧翼区域点突变以及中等大小重排的新信息。